Rina Mepani is a highly experienced Sr Scientist with a background in medical genetics and life sciences. Rina has held various roles in prestigious companies such as Spotlight Therapeutics, Agenovir Corporation, and Dana-Farber Cancer Institute. With a Master of Science in Medical Genetics from Brunel University London, Rina has a strong foundation in research and gene editing.
December 1, 2023 - present
September, 2019
April, 2018